Resoimplant GmbH successfully closes third financing round – 2,54 Mil. Euro for the innovative medtech company from Regensburg, Bavaria
February 10, 2010
Resoimplant GmbH, Regensburg, has gained a further investor – the Bavarian Investment Company (“Bayerische Beteiligungsgesellschaft”). Together with existing shareholders – S-Refit, Regensburg; High Tech Gründerfonds, Bonn; Bayern Kapital, Landshut and FVW Beteiligungsgesellschaft GmbH, Essen; the company successfully closed a 2,54 Mil. Euro financing round. The funds will be used to develop international sales and marketing as well as accelerate the new product pipeline, especially a new fixation system for use in shoulder and ankle surgery.
Resoimplant develops, manufactures and markets resorbable double shell Expansion Systems for secure fixation of tendons, ligaments and bone fragments in orthopaedic, trauma and sports medicine applications. The innovative design allows the use of an optimal polymere for the first time and assures a complete residue-free resorbtion of the implant. No second procedure to remove the implant later is necessary which minimises risk to the patient and costs to the health care system.
“This and a new design protected by over 30 patents worldwide assure a technological differentiation for Resoimplant” says BayBG Geschäftsführer Peter Pauli regarding the new investment. “In contrast to other resorbable products on the market, which are practically all copies of metal screw-type implants, the Resoimplant products are distinctly different using a patented expansion technology which has been proven in many fields in the past decades to improve the medical treatment options.”
“We are extremely pleased to be one of the very few medtech companies in Europe to close a financing round in these difficult economic conditions. Thanks to BayBG and our existing shareholders we have been able to establish the financial basis for positive and productive future of the company” explains Resoimplant general manager Robert Guilleaume. “This investment allows use to introduce our new Resofix Plus system in the key markets in the US and in Europe. In addition we can accelerate the product development pipeline to assure a timely market launch of these new systems.
Founded in October 2006 Resoimplant GmbH, located in Regensburg, developed this innovative fixation concept. The company’s goal is to develop a platform of resorbable products with the innovative design of a two shell expansion system to provide secure and a traumatic fixation of ligaments, tendons and bones in orthopaedic surgery.
Through its investments, BayBG is currently strengthening the capital base of 540 Bavarian medium-sized businesses. The BayBG is thus the Bavarian market leader among medium-sized enterprise-oriented investment companies. Through its commitment, the BayBG enables the companies to realize expansion and innovation plans, make corporate succession plans as well as optimize the capital structure and implement of turn-around measures.
About High-Tech Gründerfonds:
High-Tech Gründerfonds invests venture capital into promising early-stage technology firms, helping to turn their Research & Development into commercial business models. With seed financing of up to 500K EUR, start-ups can be helped with R&D plans to create prototypes, “proof of concepts”, or a market launch. High-Tech Gründerfonds has about 272 mio EUR funds under management. The investors in this public-private partnership are the “Bundesministerium für Wirtschaft und Technologie“ (German Ministry of Business and Technology), the KfW banking group, and six industrial corporations BASF, Deutsche Telekom, Siemens, Robert Bosch, Daimler and Carl Zeiss.
High-Tech Gründerfonds Management GmbH
Dr. Caroline Fichtner
Phone: +49 228 96568500
Fax: +49 228 96568550